Clinical Summary
Clinical Summary: Side Effect Profiles of Selective Serotonin Reuptake Inhibitors: A Cross-Sectional Study in a Naturalistic Setting
Patients often stay on SSRIs for long periods, yet the adverse effects captured in clinical trials can miss what shows up in routine practice and what drives nonadherence. This study gives a real-world look at patient-reported side effects with sertraline, escitalopram, and fluoxetine, highlighting which problems were most common and where between-drug differences emerged.
Design
A cross-sectional study in a naturalistic setting
N
A total of 100 patients participated in the study
Population
The subjects were patients (aged ≥ 18 years) diagnosed with any psychiatric disorder according to ICD-10 criteria and who were on SSRI monotherapy.
Setting
The subjects were outpatients recruited from a psychiatry department in a tertiary care hospital.
Key Findings
- The most commonly reported side effects were flatulence (64%), somnolence (59%), memory impairment (51%), decreased concentration (50%), yawning (47%), fatigue (45%), dry mouth (45%), weight gain (45%), light headedness (43%), and sweating (38%).
- Patients treated with escitalopram showed significantly higher incidence of headache (χ2 = 6.522, P = .038), pruritus (χ2 = 9.910, P = .007), memory impairment (χ2 = 6.324, P = .042), decreased concentration (χ2 = 8.074, P = .018), and dizziness (χ2 = 10.162, P = .006).
- Patients treated with sertraline showed significantly decreased appetite (χ2 = 6.136, P = .047).
- The sample was predominantly female (70%), and the most common diagnosis was depression (49%), followed by panic disorder (14%) and obsessive-compulsive disorder (13%).
- SSRI use in this cohort was distributed as 53% sertraline, 38% escitalopram, and 8% fluoxetine, with no significant statistical difference in age, sex, or duration of SSRI administration across the 3 groups.
Clinical Bottom Line
In routine outpatient practice, SSRI adverse effects were common and often cognitive, gastrointestinal, sleep-related, and constitutional rather than limited to the classic complaints emphasized in trials. Escitalopram showed higher rates of several patient-reported adverse effects, while sertraline was associated with more decreased appetite.
Practice Implications
- Ask directly about flatulence, somnolence, memory impairment, decreased concentration, dry mouth, weight gain, and light headedness, since each was reported by 43% to 64% of patients.
- When prescribing escitalopram, monitor specifically for headache, pruritus, memory impairment, decreased concentration, and dizziness because these differed significantly from the other SSRIs studied.
- When prescribing sertraline, check for decreased appetite and discuss whether it is affecting intake or adherence.
- Use both a structured review and an open-ended question about side effects, as additional patient-reported events included apathy and hair loss with sertraline and shortness of breath with escitalopram.
